US pharmaceutical giant Merck to get new CEO
[NEW YORK] US pharmaceutical giant Merck said Thursday that chief executive Ken Frazier will retire on June 30.
Mr Frazier, one of few African Americans to run a major US company, will stay on the board as executive chairman during a transition period, a statement said.
Word of the change in leadership came as Merck reported profits of US$7.1 billion in 2020, a decline of 28 per cent from the previous year, on revenue of US$48 billion, which was up by 2.5 per cent.
AFP
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue